|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.800 USD | +6.42% |
|
+11.32% | +14.85% |
| Capitalization | 742M 635M 591M 551M 1.03B 66.84B 1.1B 6.8B 2.67B 31.98B 2.78B 2.72B 117B | P/E ratio 2025 * |
-26.7x | P/E ratio 2026 * | -26.7x |
|---|---|---|---|---|---|
| Enterprise value | 509M 435M 405M 378M 705M 45.84B 757M 4.67B 1.83B 21.93B 1.91B 1.87B 80.4B | EV / Sales 2025 * |
2.59x | EV / Sales 2026 * | 2.42x |
| Free-Float |
91.15% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Cytek Biosciences, Inc.
More recommendations
More press releases
More news
| 1 day | +6.42% | ||
| 1 week | +11.32% | ||
| Current month | +14.85% | ||
| 1 month | +19.34% | ||
| 3 months | +50.65% | ||
| 6 months | +68.12% | ||
| Current year | +14.85% |
| 1 week | 5.37 |  | 6.04 |
| 1 month | 4.56 | | 6.04 |
| Current year | 4.9 | | 6.04 |
| 1 year | 2.37 | | 7.3 |
| 3 years | 2.37 | | 13.77 |
| 5 years | 2.37 | | 28.7 |
| 10 years | 2.37 | | 28.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Yan
CTO | Chief Tech/Sci/R&D Officer | 63 | 2014-12-31 |
Wen Bin Jiang
CEO | Chief Executive Officer | 62 | 2014-11-30 |
William McCombe
DFI | Director of Finance/CFO | 68 | 2024-03-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bin Jiang
BRD | Director/Board Member | 62 | 2014-11-30 |
Jack Ball
BRD | Director/Board Member | 79 | 2018-08-31 |
Ming Yan
BRD | Director/Board Member | 63 | 2014-12-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.20% | 0.19% | 22 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.42% | +11.32% | -14.96% | -48.03% | 742M | |
| -0.55% | +0.70% | +13.49% | +5.83% | 231B | |
| -2.30% | +1.12% | +4.62% | +122.91% | 203B | |
| +0.26% | +1.55% | +1.67% | -12.23% | 169B | |
| -1.97% | +0.25% | +0.89% | +104.92% | 142B | |
| +0.28% | +4.83% | -7.23% | -4.02% | 61.2B | |
| -2.49% | -1.38% | +13.06% | +6.77% | 48.17B | |
| -0.36% | +3.54% | +7.65% | -5.43% | 41.95B | |
| -0.44% | +2.19% | +2.52% | +32.37% | 39.58B | |
| +2.13% | +5.09% | +10.27% | +20.49% | 37.56B | |
| Average | -0.12% | +2.90% | +3.20% | +22.36% | 97.42B | |
| Weighted average by Cap. | -0.99% | +1.37% | +5.59% | +42.08% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 197M 168M 157M 146M 273M 17.73B 293M 1.8B 709M 8.48B 738M 723M 31.1B | 207M 178M 165M 154M 288M 18.7B 309M 1.9B 748M 8.95B 778M 762M 32.8B |
| Net income | -27.24M -23.32M -21.69M -20.22M -37.78M -2.45B -40.52M -250M -98.21M -1.17B -102M -100M -4.31B | -29.71M -25.44M -23.66M -22.05M -41.21M -2.68B -44.2M -272M -107M -1.28B -111M -109M -4.7B |
| Net Debt | -233M -200M -186M -173M -323M -21.01B -347M -2.14B -840M -10.05B -874M -856M -36.85B | -239M -205M -191M -178M -332M -21.57B -356M -2.2B -863M -10.32B -898M -879M -37.84B |
More financial data
* Estimated data
Employees
692
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-12 | 5.800 $ | +6.42% | 1,599,707 |
| 26-01-09 | 5.450 $ | +0.37% | 983,998 |
| 26-01-08 | 5.430 $ | -1.27% | 541,754 |
| 26-01-07 | 5.500 $ | -0.36% | 924,205 |
| 26-01-06 | 5.520 $ | +5.95% | 975,000 |
Delayed Quote Nasdaq, January 12, 2026 at 04:00 pm EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
5.800USD
Average target price
6.000USD
Spread / Average Target
+3.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CTKB Stock
Select your edition
All financial news and data tailored to specific country editions
